Big Pharma Has Mad Love For These 2 Biotechs

So when I am researching a possible biotech investment, I am happy when I see collaboration. In fact, it's one of the first things I look for on a biotech's website: Right after I check out the company's pipeline, I look to see whether they have any collaborators. RegenXbio (NASDAQ:RGNX) and Denali Therapeutics (NASDAQ:DNLI) are two biotechs that pass my test with flying colors.